SuppreMol is a privately held biotech company that uses a unique approach to develop therapeutics for autoimmune and allergic diseases. Their focus is on creating soluble Fc-gamma receptors (FcyRs), which are recombinant autologous therapeutic proteins that have the potential to regulate the immune system and cure autoimmune diseases. The company is dedicated to developing new therapies that have the potential to cure autoimmune diseases, rather than just treating their symptoms.